Patent · US Active

Yeast cells having reductive TCA pathway from pyruvate to succinate and overexpressing an exogenous NAD(P)+ transhydrogenase enzyme

US9850507B2 · kind B2 · utility

3Cited by

0References

18Claims

0Family size

Assignees

CARGILL, INCORPORATED · US
BIOAMBER INC. · US

Inventors

Brian J. Rush · Minneapolis, US
Kevin T. Watts · Minneapolis, US
Vernon L. McIntosh, Jr. · Minneapolis, US
Arlene M. Fosmer · Eden Prairie, US
Gregory M. Poynter · Windom, US
Thomas W. McMullin · Manitowoc, US

Key dates

Filing date	Jul 25, 2013
Grant date	Dec 26, 2017
Priority date	—
Expiry date	Jul 25, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02E50/30
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Yeast cells having a reductive TCA pathway from pyruvate or phosphoenolpyruvate to succinate, and which include at least one exogenous gene overexpressing an enzyme in that pathway, further contain an exogenous transhydrogenase gene.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.